New research suggests testosterone therapy in postmenopausal women may be tied to a higher risk of heart attack, stroke and other cardiovascular events.
The FDA has flagged dosing errors from compounded GLP-1s that landed people in the hospital, improper storage that doesn’t ...
Too often, some experts say, providers don’t give Medicaid patients extensive options or engage in discussion to reach ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results